Bursitis epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Bursitis accounts for 400 visits per 100,000 visits to primary care clinics. The exact prevalence and incidence of bursitis are unknown.[1]
Epidemiology and Demographics
Prevalence and Incidence
- The exact incidence and prevalence of bursitis are not known.
- The incidence of septic olecranon and prepatellar bursitis is estimated to be 10 to 100 cases per 100,000 hospital admissions.[1]
- In sport medicine practice, the incidence of trochanteric bursitis was estimated to be 560 cases per 100,000 cases.[2]
Age
- Prepatellar bursitis can affect all age groups. However, the incidence of septic bursitis is higher in children, particularly immunocompromised patients.
- Olecranon bursitis affects middle-aged people (between the ages of 30 and 60 years).
- Trochanteric bursitis can affect all age groups, though the incidence of trochanteric bursitis may be higher in middle-aged to elderly adults.[3]
Gender
- Males are more commonly affected by prepatellar bursitis and septic bursitis than women.
- Females are more commonly affected by trochanteric bursitis or greater trochanteric pain syndrome (GTPS) than male. The female to male ratio is approximately 4 to 1.[3]
Race
- There is no racial predilection to bursitis.
References
- ↑ 1.0 1.1 McAfee JH, Smith DL (1988). “Olecranon and prepatellar bursitis. Diagnosis and treatment”. West J Med. 149 (5): 607–10. PMC 1026560. PMID 3074561.
- ↑ Brinks A, van Rijn RM, Bohnen AM, Slee GL, Verhaar JA, Koes BW; et al. (2007). “Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice”. BMC Musculoskelet Disord. 8: 95. doi:10.1186/1471-2474-8-95. PMC 2045096. PMID 17880718.
- ↑ 3.0 3.1 Govaert LH, van Dijk CN, Zeegers AV, Albers GH (2012). “Endoscopic bursectomy and iliotibial tract release as a treatment for refractory greater trochanteric pain syndrome: a new endoscopic approach with early results”. Arthrosc Tech. 1 (2): e161–4. doi:10.1016/j.eats.2012.06.001. PMC 3678627. PMID 23766989.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH